News & Articles

Study will assess the immune response of the vaccine which is based on a genetically modified version of a common cold virus

New preclinical data further supports ability of CM-101 to break the vicious cycle of inflammation and fibrosis in primary sclerosing cholangitis

First clinical trial injecting naked mRNA directly into the heart of patients undergoing elective coronary artery bypass surgery

The first patients have been enrolled in this trial to help treatment for Amyotrophic Lateral Sclerosis (ALS)

DAPA-CKD Phase III trial sub-analyses showed that kidney and cardiovascular outcomes were consistent

Watch this on-demand webinar with Dr. Cheryl Frydman to discover the importance of measuring pH in pleural fluid when making diagnostic decisions

A flow cytometry technician shares how live high-speed image capture increases the range of information obtained from limited sample materials

We’ve rounded up the latest clinical news and technological advancements which made waves at this year’s conference

New life sciences brand enables breakthroughs to market with a fully integrated portfolio which promises unparalleled sample exploration and management solutions

The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance

Chemomab’s CM-101 is a first-in-class, CCL24-neutralizing monoclonal antibody expected to enter a Phase 2 clinical trial in SSc patients early next year

A study by researchers at Oxford University found that we are amidst the biggest decrease in life expectancy since WWII

How scientists at Kato Pharmaceuticals have expanded from early-stage development to biopharmaceutical production of clinical drug products

These findings are the first evidence that a pre-emptive intervention during infancy could lead to a child falling below the threshold for a clinical diagnosis of autism

First dose delivered to patients in a multi-center U.S. clinical trial to evaluate novel gamma-delta T cell cancer therapy

Offering user-friendly, efficient specimen collection, the Combo Swab is expected to dramatically improve COVID-19 testing efficiency

Using Cytel’s expertise, the TOGETHER Trial simultaneously tests multiple repurposed therapies

Amulet device is the first minimally invasive option approved for left atrial appendage occlusion that does not require blood-thinning medication

Researchers announce the results of a study into thrombocytopenia and thromboembolic events following Covid-19 vaccination

Adults who have received a double vaccination are 47% less likely to have long COVID

Opaganib demonstrated strong inhibition of COVID-19 Delta variant in a human bronchial epithelial cell model

Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant

Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks